Previously, it has been demonstrated that a higher CD8+ T cell infiltrate in the skin is correlated with better prognosis in patients across plaque-stage MF, tumor stage MF, and CD30- PCTCL, and is correlated with less aggressive disease [24]. Here, TNFRSF8 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.